Integra LifeSciences Holdings Corporation (IL3.F)

24,00 +0,60 (+2,56%) Ab 08:12AM CEST. Markt geöffnet.

Integra LifeSciences Holdings Corporation

1100 Campus Road
Princeton, NJ 08540
United States
609 275 0500
https://www.integralife.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 3.946

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Stuart M. Essig Ph.D.	Executive Chairman	141,39k	N/A	1962
Mr. Jan De Witte	President, CEO & Director	823,91k	N/A	1964
Ms. Lea Daniels Knight	Executive VP & CFO	624,09k	N/A	1972
Mr. Jeffrey A. Mosebrook	Senior VP of Finance & Principal Accounting Officer	457,2k	N/A	1976
Mr. Eric Ian Schwartz	Executive VP, Chief Legal Officer & Secretary	509,47k	N/A	1969
Mr. Robert T. Davis Jr.	Executive VP & President of Tissue Technologies	490,5k	41,16k	1959
Mr. Michael J. McBreen	Executive VP & President of Codman Specialty Surgical	566,73k	N/A	1967
Mr. Stephen Leonard	Corporate VP of Global Operations & Supply Chain	N/A	N/A	1962
Mr. Mathieu Aussermeier	Vice President of Corporate Finance, Investor Relations & Treasurer	N/A	N/A	N/A
Mr. William Compton	Chief Information Officer & Corporate VP	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Corporate Governance

Integra LifeSciences Holdings Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 1. Die grundlegenden Scores sind Audit: 1, Vorstand: 4, Shareholderrechte: 1, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.